Victrex plc (LON:VCT) Insider Martin Court Acquires 600 Shares

Posted by on May 17th, 2023

Victrex plc (LON:VCT – Get Rating) insider Martin Court acquired 600 shares of the business’s stock in a transaction dated Tuesday, May 16th. The stock was purchased at an average price of GBX 1,530 ($19.17) per share, with a total value of £9,180 ($11,499.44).

Martin Court also recently made the following trade(s):

  • On Monday, April 17th, Martin Court bought 9 shares of Victrex stock. The stock was bought at an average cost of GBX 1,565 ($19.60) per share, with a total value of £140.85 ($176.44).
  • On Thursday, February 16th, Martin Court bought 8 shares of Victrex stock. The stock was bought at an average cost of GBX 1,876 ($23.50) per share, with a total value of £150.08 ($188.00).

Victrex Trading Up 0.9 %

VCT opened at GBX 1,536 ($19.24) on Wednesday. The business has a 50 day simple moving average of GBX 1,617.62 and a two-hundred day simple moving average of GBX 1,697.22. The firm has a market capitalization of £1.34 billion, a price-to-earnings ratio of 1,765.52, a PEG ratio of 1.80 and a beta of 0.83. The company has a debt-to-equity ratio of 6.54, a current ratio of 2.74 and a quick ratio of 1.99. Victrex plc has a one year low of GBX 1,479 ($18.53) and a one year high of GBX 1,953.15 ($24.47).

Victrex Cuts Dividend

The firm also recently declared a dividend, which will be paid on Monday, July 3rd. Shareholders of record on Thursday, May 25th will be given a dividend of GBX 13.42 ($0.17) per share. This represents a yield of 0.81%. The ex-dividend date is Thursday, May 25th. Victrex’s payout ratio is 6,896.55%.

Analyst Ratings Changes

Separately, Barclays lowered their target price on Victrex from GBX 2,310 ($28.94) to GBX 2,280 ($28.56) and set an “overweight” rating for the company in a research note on Friday, April 21st.

About Victrex

(Get Rating)

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities.

Featured Stories

Insider Buying and Selling by Quarter for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.